Related Experiment Videos
Myasthenia gravis: a higher than expected incidence in the elderly
J M Aragonès1, I Bolíbar, X Bonfill
1Unit of Neurology, Hospital General de Vic, Barcelona, Spain. jmaragones@hgv.es
Neurology
|March 26, 2003
Summary
This study on Myasthenia Gravis (MG) incidence in Spain found the highest rates ever reported, particularly in older adults. Population aging is a likely contributing factor to these increasing MG cases.
Area of Science:
- Neurology
- Epidemiology
Background:
- Myasthenia Gravis (MG) is a rare autoimmune disorder affecting neuromuscular junctions.
- Understanding the epidemiological trends of MG is crucial for public health planning.
Purpose of the Study:
- To determine the annual incidence of Myasthenia Gravis in Osona county, Barcelona, Spain.
- To analyze MG incidence across different age groups over a 10-year period.
Main Methods:
- Prospective cohort study conducted from 1991 to 2000.
- Data collection focused on residents of Osona county, Spain.
- Calculation of incidence rates per million inhabitants by age strata.
Main Results:
- The overall annual incidence of MG was 21.27 cases per million inhabitants.
- Incidence rates significantly increased with age: 5.03/10^6 (0-14 yrs), 14.68/10^6 (15-64 yrs), and 63.38/10^6 (>65 yrs).
- These represent the highest reported MG incidence rates to date.
Conclusions:
- The aging population in the region may explain the elevated MG incidence.
- Further research is needed to confirm the impact of demographic shifts on MG epidemiology.